Singapūra - angļu - HSA (Health Sciences Authority)

bausch & lomb (singapore) private limited - tetracaine hydrochloride - solution - 0.01g/ml - tetracaine hydrochloride 0.01g/ml

Jordānija - angļu - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع البتراء للمواد الطبية - petra drug store - tetracaine hcl 0.5 % - 0.5%

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

singular dreamer, ltd dba true marker - tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - tetracaine 1.9%.       topical analgesic for the temporary relief of: pain, associated with - minor burns  - minor cuts  - scrapes  - sunburn

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

galen us incorporated - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg - synera is a combination amide and ester local anesthetic indicated for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures such as excision, electrodessication and shave biopsy of skin lesions [see clinical studies ( 14)] . - synera is contraindicated in patients with a known history of sensitivity to lidocaine, tetracaine, or local anesthetics of the amide or ester type. - synera is also contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity and in patients with a known history of sensitivity to any other component of the product. risk summary there are no available data on synera use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not iden

Īrija - angļu - HPRA (Health Products Regulatory Authority)

alliance pharmaceuticals ltd. - tetracaine hydrochloride - gel - 40 mg/g - tetracaine

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

cetylite industries, inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), butamben (unii: efw857872q) (butamben - unii:efw857872q), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 0.028 g in 0.2 g - cetacaine is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. cetacaine spray is indicated for use to control pain or gagging. cetacaine in all forms is indicated to control pain and for use for surgical or endoscopic or other procedures in the ear, nose, mouth, pharynx, larynx, trachea, bronchi, and esophagus. it may also be used for vaginal or rectal procedures when feasible. do not use cetacaine spray or cetacaine liquid to treat infants or children younger than 2 years. cetacaine is not suitable and should never be used for injection. do not use on the eyes. to avoid excessive systemic absorption, cetacaine should not be applied to large areas of denuded or inflamed tissue. cetacaine should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinesterase deficiencies. tolerance may vary with the status of the patient. cetacaine should not be used under dentures or cotton rolls, as

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

hager worldwide, inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), butamben (unii: efw857872q) (butamben - unii:efw857872q), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 28 mg in .2 g - indications onetouch advanced gel is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. onetouch advanced gel is indicated for use to control pain in the mouth. contraindications onetouch advanced gel is not suitable and should never be used for injection. do not use on the eyes. to avoid excessive systemic absorption, onetouch advanced gel should not be applied to large areas of denuded or inflamed tissue. onetouch advanced gel should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinest-­ erase deficiencies. tolerance may vary with status of the patient.   onetouch advanced gel should not be used under dentures or cotton rolls, as retention of the active gel ingredients under a denture or cotton roll could pos-­ sibly cause an escharotic effect. routine precaution for the use of any topical anesthetic should be observed when using onetouch advanced gel.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

hager worldwide, inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), butamben (unii: efw857872q) (butamben - unii:efw857872q), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 28 mg in .2 g - indications onetouch advanced gel is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. onetouch advanced gel is indicated for use to control pain in the mouth. contraindications onetouch advanced gel is not suitable and should never be used for injection. do not use on the eyes. to avoid excessive systemic absorption, onetouch advanced gel should not be applied to large areas of denuded or inflamed tissue. onetouch advanced gel should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinest-­ erase deficiencies. tolerance may vary with status of the patient.   onetouch advanced gel should not be used under dentures or cotton rolls, as retention of the active gel ingredients under a denture or cotton roll could pos-­ sibly cause an escharotic effect. routine precaution for the use of any topical anesthetic should be observed when using onetouch advanced gel.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

hager worldwide, inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), butamben (unii: efw857872q) (butamben - unii:efw857872q), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 28 mg in .2 g - indications onetouch advanced gel is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. onetouch advanced gel is indicated for use to control pain in the mouth. contraindications onetouch advanced gel is not suitable and should never be used for injection. do not use on the eyes. to avoid excessive systemic absorption, onetouch advanced gel should not be applied to large areas of denuded or inflamed tissue. onetouch advanced gel should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinest-­ erase deficiencies. tolerance may vary with status of the patient.   onetouch advanced gel should not be used under dentures or cotton rolls, as retention of the active gel ingredients under a denture or cotton roll could pos-­ sibly cause an escharotic effect. routine precaution for the use of any topical anesthetic should be observed when using onetouch advanced gel.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

hager worldwide, inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), butamben (unii: efw857872q) (butamben - unii:efw857872q), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 28 mg in .2 g - indications onetouch advanced gel is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes. onetouch advanced gel is indicated for use to control pain in the mouth. contraindications onetouch advanced gel is not suitable and should never be used for injection. do not use on the eyes. to avoid excessive systemic absorption, onetouch advanced gel should not be applied to large areas of denuded or inflamed tissue. onetouch advanced gel should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinest-­ erase deficiencies. tolerance may vary with status of the patient.   onetouch advanced gel should not be used under dentures or cotton rolls, as retention of the active gel ingredients under a denture or cotton roll could pos-­ sibly cause an escharotic effect. routine precaution for the use of any topical anesthetic should be observed when using onetouch advanced gel.